GlakoLens Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.67M

  • Investors
  • 11

GlakoLens General Information

Description

Developer of contact lens-based biosensor technology designed for intraocular pressure and glaucoma management. The company's technology offers non-invasive continuous intraocular pressure diagnostics and monitoring devices to accurately diagnose and passively monitor fluctuations in IOP by measuring certain properties of the eye, enabling doctors to effectively treat glaucoma using various monitoring devices that offer insights.

Contact Information

Website
www.glakolens.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Boğaziçi University Technopark
  • 302 Kuzey Kampüs Bebek Yolu Sokak 2/5, Sarıyer
  • 34470 Istanbul
  • Turkey
+90 (0212)
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Vertical(s)
Wearables & Quantified Self, TMT, HealthTech, Life Sciences
Corporate Office
  • Boğaziçi University Technopark
  • 302 Kuzey Kampüs Bebek Yolu Sokak 2/5, Sarıyer
  • 34470 Istanbul
  • Turkey
+90 (0212)

GlakoLens Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GlakoLens Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC $2.67M Completed Product Development
14. Accelerator/Incubator 05-Oct-2024 Completed Pre-Clinical Trials
13. Accelerator/Incubator 13-Feb-2023 Completed Pre-Clinical Trials
12. Grant 18-Dec-2022 Completed Pre-Clinical Trials
11. Accelerator/Incubator 09-Dec-2022 Completed Pre-Clinical Trials
10. Grant 26-Feb-2022 Completed Pre-Clinical Trials
9. Secondary Transaction - Private Completed Pre-Clinical Trials
8. Accelerator/Incubator 16-Mar-2021 Completed Pre-Clinical Trials
7. Accelerator/Incubator 13-Aug-2020 $1.41M Completed Pre-Clinical Trials
6. Grant 30-Jun-2020 $80.3K $1.41M Completed Pre-Clinical Trials
To view GlakoLens’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

GlakoLens Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of contact lens-based biosensor technology designed for intraocular pressure and glaucoma management. The comp
Monitoring Equipment
Istanbul, Turkey
10 As of 2024

Vantaa, Finland
 

Etagnières, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GlakoLens Competitors (4)

One of GlakoLens’s 4 competitors is Icare (Diagnostic Equipment), a Formerly VC-backed company based in Vantaa, Finland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Icare (Diagnostic Equipment) Formerly VC-backed Vantaa, Finland
Sensimed Formerly VC-backed Etagnières, Switzerland
Implandata Ophthalmic Products Venture Capital-Backed Hanover, Germany
Smartlens Venture Capital-Backed Sunnyvale, CA
To view GlakoLens’s complete competitors history, request access »

GlakoLens Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GlakoLens Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
VITA Accelerator Accelerator/Incubator Minority
Sustainable Innovation Accelerator/Incubator
Global Entrepreneur Programme Accelerator/Incubator
Tübitak Government
Association of Research-Based Pharmaceutical Companies Corporation
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

GlakoLens FAQs

  • When was GlakoLens founded?

    GlakoLens was founded in 2017.

  • Where is GlakoLens headquartered?

    GlakoLens is headquartered in Istanbul, Turkey.

  • What is the size of GlakoLens?

    GlakoLens has 10 total employees.

  • What industry is GlakoLens in?

    GlakoLens’s primary industry is Monitoring Equipment.

  • Is GlakoLens a private or public company?

    GlakoLens is a Private company.

  • What is GlakoLens’s current revenue?

    The current revenue for GlakoLens is .

  • How much funding has GlakoLens raised over time?

    GlakoLens has raised $4.19M.

  • Who are GlakoLens’s investors?

    VITA Accelerator, Sustainable Innovation, Global Entrepreneur Programme, Tübitak, and Association of Research-Based Pharmaceutical Companies are 5 of 11 investors who have invested in GlakoLens.

  • Who are GlakoLens’s competitors?

    Icare (Diagnostic Equipment), Sensimed, Implandata Ophthalmic Products, and Smartlens are competitors of GlakoLens.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process